CNTB
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
CNTB
17 hedge funds and large institutions have $2.4M invested in Connect Biopharma Holdings Limited Ordinary Shares in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
AlphaCore Capital
La Jolla,
California
|
+$78.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$62K |
| 3 |
KWM
Koa Wealth Management
Encinitas,
California
|
+$48.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$28.9K |
| 5 |
Renaissance Technologies
New York
|
+$28.3K |
Top Sellers
| 1 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$266K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$148K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.49K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$4.64K |
